RDUS - Radius Health, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - RDUS (1428522)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
25 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P15-3-2+5+13
S10-1-3-3-40

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-03-21
RDUSBiotech Growth N V10%P - Purchase$35.83+50,0004,540,399+1%+$1,791,625+1
2017-03-17
RDUSBiotech Growth N V10%P - Purchase$38.41+30,0004,490,399+1%+$1,152,249-7
M
2017-03-14
RDUSBiotech Growth N V10%P - Purchase$39.97+61,7214,460,399+1%+$2,466,8710-3
2017-03-10
RDUSBiotech Growth N V10%P - Purchase$39.17+38,2794,398,678+1%+$1,499,285-4-9
M
2016-01-25
RDUSFitzpatrick Lorraine A.Chief Medical OfficerP - Purchase$49.28+200100-200%+$9,857-11-8-6+28
2016-01-22
RDUSBiotech Growth N V10%P - Purchase$31.67+38,2594,360,399+1%+$1,211,502-3-10-8+27
2016-01-13
RDUSBiotech Growth N V10%P - Purchase$39.90+50,0004,322,140+1%+$1,994,885-10-29-46-16
D
2015-11-23
RDUSWard RobertPres, CEOS - Sale+OE$62.77-25,0000-100%-$1,569,125+4-11-4-47
D
2015-11-12
RDUSHattersley GaryChief Scientific OfficerS - Sale+OE$75.00-5,6830-100%-$426,225-7-19-27-60
D
2015-11-03
RDUSHattersley GaryChief Scientific OfficerS - Sale+OE$70.00-13,3330-100%-$933,310-20-19-58
D
2015-10-23
RDUSHattersley GaryChief Scientific OfficerS - Sale+OE$65.00-11,3020-100%-$734,630+4+3-6-43
D
2015-10-21
RDUSHattersley GaryChief Scientific OfficerS - Sale+OE$65.36-1,5010-100%-$98,105-1-3-6-43
D
2015-10-21
RDUSWard RobPres, CEOS - Sale+OE$61.99-50,0000-100%-$3,099,500-1-1-40
2015-09-14
RDUSSnow David P.Chief Commercial OfficerP - Purchase$69.79+6,0006,000New+$418,740+6+21+4-45
2015-08-31
RDUSPurandare DineshSVP Global Oncology, CommerciaP - Purchase$62.20+200200New+$12,440-2+4+6-57
M
2015-08-20
RDUSBiotech Growth N V10%P - Purchase$64.00+100,0004,272,140+2%+$6,400,030-9+1+4-48
D
2015-08-17
RDUSGraves KurtDirS - Sale+OE$70.00-22,6940-100%-$1,588,580-8-16+5-62
D
2015-08-10
RDUSGraves KurtDirS - Sale+OE$70.00-2,3060-100%-$161,420-2+5-4-58
2015-07-23
RDUSBiotech Growth N V10%P - Purchase$74.00+250,0004,172,140+6%+$18,500,000-1+6-22-52
D
2015-07-06
RDUSGraves KurtDirS - Sale+OE$69.48-25,0000-100%-$1,736,908-4+14+8-20
D
2015-06-18
RDUSGraves KurtDirS - Sale+OE$55.05-25,0000-100%-$1,376,250+4+1+25-7
2015-05-01
RDUSBiotech Growth N V10%P - Purchase$36.46+50,0003,922,140+1%+$1,822,965-2+3+31+72
2015-04-29
RDUSBiotech Growth N V10%P - Purchase$36.23+50,0003,872,140+1%+$1,811,580-1+4+33+80
2015-04-28
RDUSBiotech Growth N V10%P - Purchase$36.59+50,0003,822,140+1%+$1,829,275-1-2+31+76
2015-04-27
RDUSBiotech Growth N V10%P - Purchase$38.38+50,0003,772,140+1%+$1,919,010-1-2+31+76

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top